RxDoctor Payments Data

Valeria Hairston

Podiatrist · Milwaukee, WINPI 1669445037

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $4,589 of the $5,621 with a category attached, or 81.6%. It is spread thinly across 30 manufacturers, the largest accounting for just 22.0% — the pattern of someone who eats at a lot of different presentations.

$5,621in general payments, 2019–2025

Across 124 payments — averaging $45.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lifenet Health$1K
  • Smith+Nephew$813
  • Gilead$661
  • Medtronic$405
  • AbbVie$363
  • Kerecis Limited$257
  • plus $2K from 24 others

What the payments were for

  • Travel & lodging$1,03318%
  • Food & beverage$4,58982%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,621 in reported general payments places this provider in the 80th percentile of 140 podiatrist providers in Wisconsin.

See all podiatrist providers in Wisconsin

Most prescribed under Part D

DrugClaimsCost to plans & patients
LyricaPregabalin18$8,672
Ammonium Lactate178$4,591
Clotrimazole81$2,240
Naftifine Hcl11$1,967
Ketoconazole58$929
Diclofenac Sodium51$916
Pregabalin62$734
Gabapentin75$713
Lidocaine13$537

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerLyrica$114$8,67218 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 140 podiatrist providers in Wisconsin.

Other podiatrist in Milwaukee

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →